PD-L1 is an activation-independent marker of brown adipocytes.
about
Generation of Ca2+-independent sortase A mutants with enhanced activity for protein and cell surface labeling.Targeting cytokine therapy to the pancreatic tumor microenvironment using PD-L1 specific VHHs.Anti-CTLA-4 therapy requires an Fc domain for efficacy.Adipose PD-L1 Modulates PD-1/PD-L1 Checkpoint Blockade Immunotherapy Efficacy in Breast CancerBrown Adipose Tissue Energy Metabolism in Humans
P2860
PD-L1 is an activation-independent marker of brown adipocytes.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
PD-L1 is an activation-independent marker of brown adipocytes.
@en
type
label
PD-L1 is an activation-independent marker of brown adipocytes.
@en
prefLabel
PD-L1 is an activation-independent marker of brown adipocytes.
@en
P2093
P2860
P1476
PD-L1 is an activation-independent marker of brown adipocytes.
@en
P2093
Camilo Espinosa
Edmund J Keliher
Hidde L Ploegh
Jessica R Ingram
Marko Knoll
Michael Dougan
Mohammad Rashidian
Olga S Blomberg
Sarah Garrett
P2860
P2888
P356
10.1038/S41467-017-00799-8
P407
P577
2017-09-21T00:00:00Z